Elevated levels of soluble CD40 ligand in patients with Sjogren's syndrome

被引：0
|
作者：
Ohashi, H [1 ]
Karahshi, T [1 ]
Kondoh, S [1 ]
Hayashi, H [1 ]
机构：
[1] Hamamatsu Univ Sch Med, Dept Internal Med 3, Hamamatsu, Shizuoka 4313192, Japan
来源：
JOURNAL OF RHEUMATOLOGY | 2001年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
W146
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [21] CD40 as a therapeutic target in Sjogren's syndrome
    Jobling, Kerry
    Ng, Wan Fai
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (07) : 535 - 537
  • [22] Assessment of serum soluble CD40 ligand levels in patients with chronic rhinosinusitis
    Liu, Zhichen
    Fan, Yuhui
    Zhou, Aina
    Liu, Jisheng
    Jiao, Qingqing
    WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (03):
  • [23] Elevated soluble CD40 ligand (sCD40L) levels in the serum of patients with B cell lymphoma.
    Clodi, K
    McDuff, B
    Zhao, S
    Kliche, KO
    Palmer, JL
    Cabanillas, F
    Andreeff, M
    Younes, A
    BLOOD, 1997, 90 (10) : 326 - 326
  • [24] Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera
    Vakkalanka, RK
    Woo, C
    Kirou, KA
    Koshy, M
    Berger, D
    Crow, MK
    ARTHRITIS AND RHEUMATISM, 1999, 42 (05): : 871 - 881
  • [25] Elevated circulating soluble CD40 ligand in patients with mixed connective tissue disease
    M. Jinnin
    H. Ihn
    N. Yazawa
    Y. Asano
    K. Yamane
    K. Tamaki
    Clinical Rheumatology, 2003, 22 : 37 - 39
  • [26] Elevated circulating soluble CD40 ligand in patients with mixed connective tissue disease
    Jinnin, M
    Ihn, H
    Yazawa, N
    Asano, Y
    Yamane, K
    Tamaki, K
    CLINICAL RHEUMATOLOGY, 2003, 22 (01) : 37 - 39
  • [27] Plasma levels of soluble CD40 ligand in essential hypertension
    Gorgojo, CN
    Beloqui, O
    Fernández, JAP
    Lopategui, JO
    Martinez, JD
    Cenarruzabeitia, NV
    JOURNAL OF HYPERTENSION, 2005, 23 : S53 - S53
  • [28] Soluble CD40 ligand plasma levels in lung cancer
    Roselli, M
    Mineo, TC
    Basili, S
    Martini, F
    Mariotti, S
    Aloe, S
    Del Monte, G
    Ambrogi, V
    Spila, A
    Palmirotta, R
    D'Alessandro, R
    Davì, G
    Guadagni, F
    Ferroni, P
    CLINICAL CANCER RESEARCH, 2004, 10 (02) : 610 - 614
  • [29] Increased soluble CD40 ligand levels in cystic fibrosis
    Falco, A
    Romano, M
    Iapichino, L
    Collura, M
    Davi, G
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (04) : 557 - 560
  • [30] Activated platelets are the source of elevated levels of soluble (S) CD40 ligand (L) in the circulation of inflammatory bowel disease (IBD) patients
    Danese, S
    Katz, J
    Saibeni, S
    Papa, A
    Gasbarrini, A
    Vecchi, M
    Fiocchi, C
    GASTROENTEROLOGY, 2003, 124 (04) : A73 - A73
12345